Physician profile
David E Leeman
NPI 1932193851
$607.05
in general payments reported to CMS, 2019-2025
10 companies · $312 in 2025
The $312 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.92 · 2022: $19.22 · 2023: $49.71 · 2024: $201 · 2025: $312.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $562.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $153.59 | 2025 | |
| Heartflow, INC. | $134.55 | 2024 | |
| Stryker Corporation | $119.60 | 2025 | Flowtriever |
| Abbott Laboratories | $44.14 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $41.07 | 2024 | |
| Boston Scientific Corporation | $26.30 | 2023 | Avvigo Guidance System |
| Esperion Therapeutics, INC. | $25.87 | 2024 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $23.41 | 2023 | Camzyos |
| Alnylam Pharmaceuticals INC. | $22.30 | 2025 | Amvuttra |
| Terumo Medical Corporation | $16.22 | 2025 | Tr Band |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Leeman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.